G1359A polymorphism of the cannabinoid receptor gene (CNR1) and insulin resistance in patients with diabetes mellitus type 2 Relación del polimorfismo G1359A del receptor endocanabinoide CB1 y la resistencia a la insulina en pacientes con diabetes mellitus tipo 2

G1359A polymorphism of the cannabinoid receptor gene (CNR1) and insulin resistance in patients with diabetes mellitus type 2 Relación del polimorfismo G1359A del receptor endocanabinoide CB1 y la resistencia a la insulina en pacientes con diabetes mellitus tipo 2

Background: A silent intragenic biallelic polymorphism (1359 G/A) (rs1049353) of the CB1 gene resulting in the substitution of the G to A at nucleotide position 1359 in codon 435 (Thr), was reported as a common polymorphism in Caucasian populations. Objective: The aim of our study was to investigate...

Full description

Bibliographic Details
Main Authors:	D. A. de Luis, M. González Sagrado, R. Aller, O. Izaola, R. Conde, E. Romero
Format:	Article
Language:	English
Published:	Arán Ediciones, S. L. 2010-02-01
Series:	Nutrición Hospitalaria
Subjects:	Gen del receptor cannabinoide Diabetes mellitus Insulin resistencia Polimorfismo Cannabinoid receptor gene Insulin resistance Polymorphism
Online Access:	http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112010000100005

Similar Items

Roles of G1359A polymorphism of the cannabinoid receptor gene (CNR1) on weight loss and adipocytokines after a hypocaloric diet Papel del polimorfismo G1359A del gen del receptor endocanabinoide tipo 1 (CNR1) en la perdida de peso y adipocitoquinas tras una dieta hipocalórica
by: D. A. De Luis, et al.
Published: (2011-04-01)

G1359A polimorfismo del receptor CB1 endocanabinoide (CNR1) en parámetros antropométricos y riesgo cardiovascular en pacientes con obesidad mórbida G1359A polymorphism of the Cannabinoid Receptor Gene (CNR1) on anthropometric parameters and cardiovascular risk factors in patients with morbid obesity
by: D. A. de Luis, et al.
Published: (2009-12-01)

Association Between Cannabinoid Receptor-1 Gene Polymorphism and the Risk of Diabetic Nephropathy Among Patients with Type 2 Diabetes Mellitus
by: Zhang X, et al.
Published: (2020-11-01)

Cannabinoid 2 Receptor Agonist Improves Systemic Sensitivity to Insulin in High-Fat Diet/Streptozotocin-Induced Diabetic Mice
by: Xiuyuan Zhang, et al.
Published: (2016-12-01)

Diabetes mellitus associated with type A insulin resistance
by: E. A. Sechko, et al.
Published: (2023-07-01)

Insulin aspart in patients with gestational diabetes mellitus and pregestational diabetes mellitus
by: M C Deepaklal, et al.
Published: (2015-01-01)

ISOLATION AND CHARACTERIZATION OF INSULIN RECEPTOR OF PLASMA MEMBRANES OF RAT LIVER CELLS AT MODEL OF TYPE 2 DIABETES
by: T. I. Halenova, et al.
Published: (2014-06-01)

O significado do ensino por telefone sobre a insulina para pessoas com diabetes Mellitus El significado del enseñanza por teléphono sobre la insulina para personas con diabetes Mellitus The meaning of teaching by telephone on the insulin for patients with diabetes Mellitus
by: Camila Aparecida Pinheiro Landim, et al.
Published: (2011-09-01)

Anti-Inflammatory and Pro-Autophagy Effects of the Cannabinoid Receptor CB2R: Possibility of Modulation in Type 1 Diabetes
by: Qing-Rong Liu, et al.
Published: (2022-01-01)

Fatores relacionados à autoaplicação de insulina em indivíduos com diabetes mellitus
by: Tiago Ricardo Moreira, et al.
Published: (2018-08-01)

Alcoholism and Diabetes Mellitus
by: Soo-Jeong Kim, et al.
Published: (2012-04-01)

Papel de la insulina en el tratamiento de la diabetes mellitus tipo II
by: Alberto Quirantes Hernández, et al.
Published: (1997-10-01)

The role of the CNR1 gene in schizophrenia: a systematic review including unpublished data
by: Eduardo S. Gouvêa, et al.

Association among insulin receptor substrate1 genetic polymorphism, sulfonylurea therapeutic efficacy, and insulin resistance in patients with type 2 diabetes mellitus
by: Ghada A Omar, et al.
Published: (2021-01-01)

Theoretical basis of perinatology therapy in pregnant women with diabetes mellitus
by: Dugalic Stefan, et al.
Published: (2022-12-01)

Differential activation of G protein‐mediated signaling by synthetic cannabinoid receptor agonists
by: Shivani Sachdev, et al.
Published: (2020-04-01)

Diabetes mellitus and suicide
by: Siddharth Sarkar, et al.
Published: (2014-01-01)

The Prelude on Novel Receptor and Ligand Targets Involved in the Treatment of Diabetes Mellitus
by: Venu Gopal Jonnalagadda, et al.
Published: (2014-05-01)

Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR)
by: Fisman Enrique Z, et al.
Published: (2003-03-01)

Uso da caneta injetora de insulina no tratamento do diabetes mellitus tipo 1 Insulin pen injector for the treatment of type 1 diabetes mellitus
by: Frederico F.R. Maia, et al.
Published: (2002-01-01)

Humalog Mix 25 in the treatment of type 2 diabetes mellitus
by: Vladimir Ivanovich Zoloedov, et al.
Published: (2012-06-01)

Synthesis, molecular docking, and pharmacological evaluation of 5-(4-(2-(5-ethyl pyridine-2-yl) ethoxy) benzyl)-3-(phenylsulfonyl) thiazolidine-2, 4-dione against HFD-induced diabesity via interaction with the CB1 receptor
by: Farah Deeba, et al.
Published: (2022-08-01)

Diabetes Mellitus: A Review
by: Kamal Mehta
Published: (2017-04-01)

Biosulin P and biosulin H in the treatment of diabetes mellitus
by: I I Dedov, et al.
Published: (2004-01-01)

Diabetes mellitus due to biliary recurrent pancreatitis. Case report
by: Elena Alexandrovna Kharlashina, et al.
Published: (2011-06-01)

Diabetes Mellitus and Its Metabolic Complications: The Role of Adipose Tissues
by: Lowell Dilworth, et al.
Published: (2021-07-01)

Profile Evaluation of Medication, Cost Comparison, and Clinical Outcome of Human and Analog Insulin Treatment to Type-2 Diabetes Mellitus Outpatient at Medistra Hospital Year 2012-2013
by: Elisabeth Ninung Yuliarti, et al.
Published: (2020-12-01)

Diabetes mellitus and diabetic foot ulcer: Etiology, biochemical and molecular based treatment strategies via gene and nanotherapy
by: Arokia Vijaya Anand Mariadoss, et al.
Published: (2022-07-01)

Toll-Like Receptors and Targeted Therapy in Diabetes Mellitus
by: Ali Bazi
Published: (2017-06-01)

A Study of Adiponectin in Children with Diabetes Mellitus
by: Basma A. Ali, et al.
Published: (2013-05-01)

Clinical and biochemical markers of joint damage in patients with diabetes mellitus
by: V. L. Orlenko, et al.
Published: (2020-06-01)

Clinical features of the course of overt diabetes mellitus during pregnancy
by: A. V. Tiselko, et al.
Published: (2022-03-01)

Efficacy of metformin and insulin in the management of gestational diabetes mellitus: A comparative study
by: Anupama Marnal B. A, et al.
Published: (2023-07-01)

Lipoproteína (a) está associada com níveis basais de insulina em pacientes com Diabetes Mellitus tipo 2 Lipoproteína (a) está asociada a niveles basales de insulina en pacientes con Diabetes Mellitus tipo 2 Lipoprotein (a) is associated with basal insulin levels in patients with type 2 Diabetes Mellitus
by: Syed Shahid Habib, et al.
Published: (2009-07-01)

DIABETES MELLITUS IN NEUROENDOCRINE DISEASES
by: I. V. Trigolosova, et al.
Published: (2016-02-01)

Study of phases of insulin secretion in pre-diabetes and newly diagnosed type 2 diabetes mellitus
by: Sabreena Mohtarin, et al.
Published: (2016-07-01)

RELUCTANCE OF PATIENTS WITH DIABETES MELLITUS TO INSULIN THERAPY; PSYCHOLOGICAL INSULIN RESISTANCE
by: Umair Ali, et al.
Published: (2021-04-01)

Methods for assessing insulin resistance in gestational diabetes mellitus
by: N. I. Volkova, et al.
Published: (2022-03-01)

Insulin choice in feline diabetes mellitus
by: Yaiza Gomez Mejias
Published: (2021-08-01)

Malnutrition-Modulated Diabetes Mellitus in Children, Rare Disease with Atypical Presentation: Case Report
by: Haftu H, et al.
Published: (2020-08-01)